Patents by Inventor Steven Heightman

Steven Heightman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for double sequential defibrillation
    Patent number: 11406839
    Abstract: A defibrillation device for administering an electrotherapy, such as a dual-sequential defibrillation (DSD) electrotherapy. The defibrillation device can include a defibrillation therapy module, a physiological parameter module and a control module. The defibrillation therapy module can output one or more energies and the physiological parameter module can receive one or more physiological parameters, including electrocardiogram (ECG) data. The control module can analyze the physiological parameters to determine an indication for the administration of an electrotherapy and can determine a DSD electrotherapy. The DSD electrotherapy can be based at least in part on the physiological parameters, the indication for the administration of an electrotherapy or a review of the ECG data.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: August 9, 2022
    Assignee: Physio-Control, Inc.
    Inventors: Fred W. Chapman, Robert G. Walker, Mitchell A. Smith, Blaine Krusor, William E. Crone, David J. Linville, Steven Heightman, Tyson G. Taylor
  • SYSTEMS AND METHODS FOR DOUBLE SEQUENTIAL DEFIBRILLATION
    Publication number: 20200316393
    Abstract: A defibrillation device for administering an electrotherapy, such as a dual-sequential defibrillation (DSD) electrotherapy. The defibrillation device can include a defibrillation therapy module, a physiological parameter module and a control module. The defibrillation therapy module can output one or more energies and the physiological parameter module can receive one or more physiological parameters, including electrocardiogram (ECG) data. The control module can analyze the physiological parameters to determine an indication for the administration of an electrotherapy and can determine a DSD electrotherapy. The DSD electrotherapy can be based at least in part on the physiological parameters, the indication for the administration of an electrotherapy or a review of the ECG data.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 8, 2020
    Applicant: Physio-Control, Inc.
    Inventors: Fred W. Chapman, Robert G. Walker, Mitchell A. Smith, Blaine Krusor, William E. Crone, David J. Linville, Steven Heightman, Tyson G. Taylor
  • Systems and methods for double sequential defibrillation
    Patent number: 10625088
    Abstract: A defibrillation device for administering an electrotherapy, such as a dual-sequential defibrillation (DSD) electrotherapy. The defibrillation device can include a defibrillation therapy module, a physiological parameter module and a control module. The defibrillation therapy module can output one or more energies and the physiological parameter module can receive one or more physiological parameters, including electrocardiogram (ECG) data. The control module can analyze the physiological parameters to determine an indication for the administration of an electrotherapy and can determine a DSD electrotherapy. The DSD electrotherapy can be based at least in part on the physiological parameters, the indication for the administration of an electrotherapy or a review of the ECG data.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: April 21, 2020
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Fred W. Chapman, Robert G. Walker, Mitchell A. Smith, Blaine Krusor, William E. Crone, David J. Linville, Steven Heightman, Tyson G. Taylor